
Beijing Dilun Biotechnology Co., Ltd., abbreviated as Dilun Biotechnology, focuses on providing comprehensive solutions for production peptide synthesis, lysis, cyclization, filtration, dissolution, etc. for CDMO and pharmaceutical enterprises. The independently developed peptide synthesizer and peptide lyser operate according to standard procedures throughout the entire process, and can be freely switched between fully automatic/semi-automatic, remote/on-site operations. All data is synchronized and backed up to the user confirmed database.
Dilun Biotech, under the guidance of Peptide Scientific Inc., also known as PSI, was founded in New York, USA in 2002. PSI has launched a series of peptide synthesizers including multi-channel, research and development, pilot testing, and production. PSI is the inventor of the "overall 180 degree up and down flipping of the reactor" mixing mode without stirring blades. Its coupling efficiency is high, and Dylan Biotech will continue to provide research and development services for PSI synthesizers.
Dylan Biology, an American Advanced ChemTech, or ACT for short, is an authorized maintenance service provider of peptide synthesizer in Chinese Mainland. Founded in Kentucky, USA, in 1985, ACT successfully developed Tetras peptide extraction 106 channel peptide synthesizer. Tetras is applicable to the construction of customized peptides, antigenic peptides, catalog products, peptide libraries and micro peptide libraries. Tetras is the mainstream equipment for super multi-channel peptide synthesis used by global peptide customization service companies.
Understand our dynamics
2024
11-262024
11-192024
10-24About us
Case
Product navigation
© 2025 Beijing Dilun Biotechnology Co., Ltd All right reserved
Technical support:Chemical Industry Instrument Website Admin sitemap.xml